Literature DB >> 9751140

Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.

S Ridray1, N Griffon, V Mignon, E Souil, S Carboni, J Diaz, J C Schwartz, P Sokoloff.   

Abstract

Using double in situ hybridization, we found extensive coexpression of dopamine D1 and D3 receptor (D1R and D3R) mRNAs in neurons of the island of Calleja major (ICjM) and ventromedial shell of nucleus accumbens (ShV), respectively. Thus, at least 79 and 63% of D3R mRNA-expressing neurons in ICjM and ShV also expressed the D1R mRNA. Coexpression of D1R and D3R mRNAs was found to occur in substance P (SP) mRNA-expressing neurons in both areas, suggesting SP mRNA as a marker of the activity of coexpressing neurons. Administration of SKF 38393, a D1R receptor agonist, increased c-fos mRNA in ICjM, whereas administration of quinpirole, a D2R/D3R agonist, decreased it; SCH 23390, a D1 R antagonist and nafadotride, a preferential D3R antagonist, given alone, had effects opposite to those of the corresponding agonists. These data indicate that basal c-fos expression in ICjM is maintained by endogenous dopamine acting tonically upon two receptor subtypes subserving opposite effects on the same cell. However, in ShV, whereas SKF 38393 also increased c-fos mRNA, quinpirole had no effect, a difference presumably reflecting the lower fraction of neurons coexpressing D1R and D3R in this area. In contrast, in ShV from reserpine-treated rats, SKF 38393 increased SP mRNA and quinpirole potentiated this effect. These contrasting interactions of D1R- and D3R-mediated signalling events, i.e. in either opposite or synergistic directions, most likely occurring at the single cell level, may serve to increase the dopamine response threshold of the target cells in ICjM and to maintain a strong tonic activity of ShV neurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751140     DOI: 10.1046/j.1460-9568.1998.00173.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  30 in total

1.  Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking.

Authors:  Liping Chen; Ming Xu
Journal:  J Neurochem       Date:  2010-04-28       Impact factor: 5.372

2.  Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors.

Authors:  John Y F Wong; Jeremiah J Clifford; Jim S Massalas; Anthony Kinsella; John L Waddington; John Drago
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

Review 3.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

4.  Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum.

Authors:  Daniel Marcellino; Sergi Ferré; Vicent Casadó; Antonio Cortés; Bernard Le Foll; Carmen Mazzola; Filippo Drago; Oliver Saur; Holger Stark; Aroa Soriano; Chanel Barnes; Steven R Goldberg; Carme Lluis; Kjell Fuxe; Rafael Franco
Journal:  J Biol Chem       Date:  2008-07-21       Impact factor: 5.157

Review 5.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

Review 6.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

7.  Intranasal delivery of a peptide with antidepressant-like effect.

Authors:  Virginia Brown; Fang Liu
Journal:  Neuropsychopharmacology       Date:  2014-03-17       Impact factor: 7.853

8.  C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.

Authors:  R K McNamara; B Levant; B Taylor; R Ahlbrand; Y Liu; J R Sullivan; K Stanford; N M Richtand
Journal:  Neuroscience       Date:  2006-08-28       Impact factor: 3.590

9.  Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats.

Authors:  Elissa M Strome; Athanasios P Zis; Doris J Doudet
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

10.  Divergent effect of the selective D3 receptor agonist pd-128,907 on locomotor activity in Roman high- and low-avoidance rats: relationship to NGFI-A gene expression in the Calleja islands.

Authors:  Marc Guitart-Masip; Björn Johansson; Albert Fernández-Teruel; Adolf Tobeña; Lydia Giménez-Llort
Journal:  Psychopharmacology (Berl)       Date:  2007-10-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.